Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 248
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07249034 BRAVE — Impact of Epilepsy on the Brainstem Adenosine Pathway and Its R… |
1 Hypercapnic challenge while par… | Épilepsie | Non applicable | RECRUITING | En attente / non publié | Hospices Civils de Lyon | France · Hospices Civils de Lyon, Bron, France | 2026-10-01 → 2028-12-01 | Ouvrir |
| NCT02107989 Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and… |
MRI | Épilepsie | À vérifier | RECRUITING | En attente / non publié | Ohio State University Comprehensi… | United States · National Institutes of Health Clinica… | 2014-03-11 → 2028-03-30 | Ouvrir |
| NCT05716100 A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X… |
XEN1101 | Épilepsie | Phase 3 | RECRUITING | En attente / non publié | Xenon Pharmaceuticals Inc. | United States, Argentina, Australia, Austria, Belgium… | 2023-05-09 → 2028-03 | Ouvrir |
| NCT07594158 A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanes… |
Cenobamate (tablet) for 12 to < 1… | Épilepsie | Phase 3 | RECRUITING | En attente / non publié | Ono Pharmaceutical Co., Ltd. | Japan · Japan Red Cross Fukuoka Hospital, Fukuoka, Ja… | 2026-06-10 → 2029-12-31 | Ouvrir |
| NCT05439876 Getting SMART for Pediatric Epilepsy |
Melatonin | Épilepsie | Phase 2/3 | COMPLETED | En attente / non publié | Nishtar Medical University | Taiwan · National Taiwan University Hospital, Taipei,… | 2022-07-18 → 2025-01-03 | Ouvrir |
| NCT05803434 CBD_RE — Cannabidiol in Children and Young Adults With Rare Disease-ass… |
Cannabidiol Oral Solution | Épilepsie | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Jazz Pharmaceuticals | Italy · Meyer Children's Hospital IRCCS, Florence, It… | 2024-03-14 → 2026-12-01 | Ouvrir |
| NCT05066217 An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-G… |
Clemizole HCl | Épilepsie | Phase 3 | RECRUITING | En attente / non publié | Epygenix | United States, China, Hungary, India, Italy, Poland, … | 2025-04-09 → 2029-11-01 | Ouvrir |
| NCT06769659 A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years… |
NPT 2042 | Épilepsie | Phase 2 | COMPLETED | En attente / non publié | NeuroPro Therapeutics, Inc. | United States · Clinical Trials, Inc. (CTI), Little R… | 2025-03-11 → 2026-09-23 | Ouvrir |
| NCT04653012 EpiMicro — Multi-level Approach of Brain Activity Using Intracranial El… |
Intracranial macro-microelectrode… | Épilepsie | Non applicable | RECRUITING | En attente / non publié | Institut National de la Santé Et … | France · Hôpital de la Salpêtrière, Paris, France | 2021-02-28 → 2031-02-27 | Ouvrir |
| NCT05232630 FENDEEP — Fenfluramine for the Treatment of Different Types of Developm… |
fenfluramine | Épilepsie | Phase 4 | COMPLETED | En attente / non publié | KU Leuven | Spain · Hospital Ruber Internacional, Madrid, Spain | 2022-10-20 → 2024-12-31 | Ouvrir |
| NCT07680322 Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Co… |
AV078 | Épilepsie | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Aeovian Pharmaceuticals, Inc. | Canada · London Health Sciences Centre, London, Canada | 2026-09-01 → 2027-12-21 | Ouvrir |
| NCT07228338 Cholinergic Enhancement of Theta |
COBENFY KarXT (50/20 mg) | Épilepsie | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | University of Texas Southwestern … | United States · University of Texas Southwestern Medi… | 2026-12 → 2031-12 | Ouvrir |
| NCT07847918 A Fully Remote Feasibility Trial of Phenylbutyrate for SLC6A1-Related D… |
Glycerol Phenylbutyrate | Épilepsie | Phase 2 | RECRUITING | En attente / non publié | Scripps Translational Science Ins… | United States · Scripps Research Translational Instit… | 2026-10 → 2032-10 | Ouvrir |
| NCT06798896 RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study … |
SPN-817 | Épilepsie | Phase 2 | RECRUITING | En attente / non publié | Supernus Pharmaceuticals, Inc. | United States, Australia, Bulgaria, Hungary, Poland ·… | 2024-12-30 → 2027-08 | Ouvrir |
| NCT06038929 Effect of Vagal Nerve Stimulation on Gastric Motor Functions |
Vagal nerve stimulant | Épilepsie | Non applicable | RECRUITING | En attente / non publié | Mayo Clinic | United States · Mayo Clinic in Rochester, Rochester, … | 2025-09-01 → 2027-12-30 | Ouvrir |
| NCT06132893 RISE 2 — A Study to Determine if BHV-7000 is Effective and Safe in Adul… |
BHV-7000 | Épilepsie | Phase 2/3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Biohaven Therapeutics Ltd. | United States, Argentina, Austria, Belgium, Chile, Cz… | 2024-03-14 → 2026-12 | Ouvrir |
| NCT05825274 TDCs to Treat Drug-resistant Epilepsy |
Active Cathodal tDCS | Épilepsie | Non applicable | COMPLETED | En attente / non publié | Spanish Foundation for Neurometri… | United Kingdom · Bigdata4brain LTD, Liverpool, United… | 2017-01-01 → 2017-12-28 | Ouvrir |
| NCT05076838 Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy |
Diazepam Nasal Spray [Valtoco] | Épilepsie | Phase 1/2 | COMPLETED | En attente / non publié | Neurelis, Inc. | United States · AdventHealth Research Institute, Orla… | 2021-11-08 → 2025-03-11 | Ouvrir |
| NCT06612775 A Study to Evaluate the Safety, Tolerability, and Efficacy of CB03-154 … |
Test drug CB03-154 5mg group | Épilepsie | Phase 2 | RECRUITING | En attente / non publié | Shanghai Zhimeng Biopharma, Inc. | Australia · Alfred Health, Melbourne, Australia | 2024-08-14 → 2027-11 | Ouvrir |
| NCT07835594 EpHR-DP — Studying Heart Rhythms With a Wearable Sensor to Detect and P… |
Textile-based wearable electrocar… | Épilepsie | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Acibadem University | Turkey (Türkiye) · Sancaktepe Şehit Prof. Dr. İlhan V… | 2026-10-15 → 2028-10-15 | Ouvrir |
| NCT07599150 ICARE — Intracranial CArtography of Cortical Contribution to Respirator… |
SEEG monitoring | Épilepsie | Non applicable | RECRUITING | En attente / non publié | Hospices Civils de Lyon | France · Service de Neurologie Fonctionne et d'Epilep… | 2026-09-17 → 2028-09-17 | Ouvrir |
| NCT07012148 FORESITE — Optimizing Therapy in Epilepsy Using Seizure Forecasts Via E… |
UNEEG SubQ device, seizure foreca… | Épilepsie | Phase 1 | RECRUITING | En attente / non publié | Mayo Clinic | United States · Mayo Clinic in Rochester, Rochester, … | 2026-01-20 → 2029-12 | Ouvrir |
| NCT03233399 Modulating Movement Intention Via Cortical Stimulation |
Sham TMS3 stimulation | Épilepsie | Non applicable | RECRUITING | En attente / non publié | NYU Langone Health | United States · New York University School of Medicin… | 2017-07-20 → 2027-05 | Ouvrir |
| NCT06388707 A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focus… |
NaviFUS System | Épilepsie | Phase 1/2 | RECRUITING | En attente / non publié | NaviFUS Corporation | United States · Brigham and Women's Hospital, Boston,… | 2024-09-13 → 2027-10-31 | Ouvrir |
| NCT05339126 RNS System LGS Feasibility Study |
RNS System | Épilepsie | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | NeuroPace | United States · Emory University, Atlanta, United Sta… | 2022-10-04 → 2026-12-31 | Ouvrir |